Searchable abstracts of presentations at key conferences in endocrinology

ea0056gp15 | Adrenal Case reports | ECE2018

Etomidate for the management of severe hypercortisolaemia in different clinical scenarios – a case series

Lebek-Szatanska Agnieszka , Nowak Karolina M , Zgliczynski Wojciech , Papierska Lucyna

Cushing’s syndrome is associated with life-threatening complications, as well as high rates of perioperative mortality and morbidity. Authors present clinical scenarios, in which one should consider the usage of intravenous etomidate as an accurate, safe and effective drug for hypercortisolaemia.Case 1: 23-year-old female with severe Cushing’s syndrome due to metastatic adrenocortical carcinoma was admitted to the Department of Endocrinology. S...

ea0067gp17 | Poster Presentations | EYES2019

Etomidate as a treatment option in severe ACTH-dependent (ectopic) Cushing syndrome

Nowak Karolina M , Łebek-Szatańska Agnieszka , Papierska Lucyna

Background: Etomidate is mainly used in general anesthesia. In some rare cases it can also be helpful in treating life-thretening severe hypercortisolaemia (in much lower doses) in patients who are not able to take oral medications or when oral drugs are not available.Case Presentation: Fifty-seven-year-old woman with symptoms of virilization, hypokalemia and muscle weekness for 6 months was admitted to Department of Endocrinology. On admission cortisol ...

ea0041ep593 | Endocrine tumours and neoplasia | ECE2016

Prognostic factors of recurrence-free and overall survival in 52 patients with adrenocortical carcinoma

Nowak Karolina M. , Samsel Radoslaw , Cichocki Andrzej , Roszkowska-Purska Katarzyna , Kasperlik-Zaluska Anna , Papierska Lucyna

Adrenocortical carcinoma (ACC) is a rare and very aggressive tumor with poor prognosis. The aim of the study was to identify prognostic factors of recurrence-free (RFS) and overall survival (OS) in patients with ACC.We present a retrospective analysis in 52 patients diagnosed with ACC. A number of factors both histological and clinical were analyzed. Recurrent disease was defined as a new lesion confirmed in imaging. Kaplan-Meier method and multivariate ...

ea0067o15 | Oral Presentations | EYES2019

Aldosterone-to-renin ratio as an accurate diagnostic tool in patients on antihypertensive therapy

Łebek-Szatańska Agnieszka , Glinicki Piotr , Nowak Karolina M , Rdzanek Monika , Zgliczyński Wojciech , Papierska Lucyna

Objective: Withdrawal of the medications prior to screening for primary aldosteronism is problematic, sometimes impossible and probably not necessary as the routine practice. The aim of this study was to evaluate diagnostic accuracy of aldosterone-to-renin ratio in hypertensive patients undergoing laboratory screening for primary aldosteronism without obligatory drug modifications.Methods: Plasma aldosterone and direct renin concentrations from 20 patien...

ea0067o17 | Oral Presentations | EYES2019

Impact of glucocorticoid receptor gene polymorphisms on occurrence of steroid-induced adverse events

Nowak Karolina M , Sobalska-Kwapis Marta , Rdzanek Monika , Romanowska-Prochnicka Katarzyna , Nowakowska-Płaza Anna , Papierska Lucyna

Objective: Previous studies indicated that two glucocorticoid receptor gene polimorphisms bclI and N363S (GC-S) are associated with increased sensitivity to glucocorticoids and two other polymorphisms 9β and ER22/23EK (GC-I) are related to decreased sensitivity to glucocorticoids. The aim of the study was to determine whether these genetic changes can effect on the occurence of steroid-induced adverse events.Methods: One hundred and fifty p...

ea0063p23 | Adrenal and Neuroendocrine Tumours 1 | ECE2019

Evaluation of angiotensin II in primary aldosteronism and other forms of hypertension – a preliminary study

Łebek-Szatańska Agnieszka , Glinicki Piotr , Walczak Maria , Nowak Karolina M , Rdzanek Monika , Zgliczyński Wojciech , Papierska Lucyna

Background: The renin-angiotensin-aldosterone system (RAS) constitutes a key hormonal system in the physiological and pathological regulation of blood pressure. In effort to understand complex and multifunctional aspects of this system, current biochemical approaches target to characterize and define its various components with angiotensin II being in the mainstream.Objective: The aim of this study was to evaluate concentrations of angiotensin II in hype...

ea0063gp11 | Adrenal and Neuroendocrine - Tumour | ECE2019

Corticotropinoma as the underlying cause of intermittent Cushing’s syndrome in a patient previously diagnosed with primary pigmented adrenocortical disease (PPNAD) – a case report

Łebek-Szatańska Agnieszka , Stelmachowska-Banaś Maria , Zieliński Grzegorz , Zgliczyński Wojciech , Nowak Karolina M. , Styk Andrzej , Maksymowicz Maria , Roszkowska-Purska Katarzyna , Papierska Lucyna

Background: The diagnostic process to unveil the underlying cause of endogenous Cushing’s syndrome (CS) is often challenging. Sometimes, atypical manifestation of the disease or only periodic hypercortisolaemia with spontaneous resolutions are observed and make the diagnosis even more difficult. Although it is common in primary pigmented nodular adrenocortical disease (PPNAD), pituitary corticotroph adenoma can manifest itself as cyclic Cushing’s syndrome as well.</p...